Literature DB >> 18976759

Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome.

Cemil Kaya1, Aycan Fahri Erkan, S Dinçer Cengiz, Ilkkan Dünder, Ozlem Erbaş Demirel, Ayşe Bilgihan.   

Abstract

OBJECTIVE: To determine whether or not plasma advanced oxidation protein products (AOPPs) are associated with known cardiovascular risk factors or carotid intima-media thickness (IMT) in patients with polycystic ovary syndrome (PCOS).
DESIGN: A prospective, controlled study.
SETTING: University hospital. PATIENT(S): Forty-six women with PCOS and 46 age- and body mass index-matched healthy women. INTERVENTION(S): Carotid IMT was evaluated for both common carotid arteries. We measured serum levels of AOPP, homocysteine (Hcy), C-reactive protein (CRP), malonyldialdehyde (MDA), vitamin B(12), folate, lipid, and hormone profiles. The presence of insulin resistance was investigated by means of homeostasis model assessment (HOMA). MAIN OUTCOME MEASURE(S): Serum AOPP, fasting insulin, HOMA index, Hcy, MDA, CRP, and carotid IMT. RESULT(S): The women with PCOS had significantly higher serum AOPP than control women. High AOPP was defined as equaling or exceeding the mean + 2 SD of the plasma AOPP in control subjects (56.2 pg/mLl). Carotid IMT, fasting insulin, HOMA index, Hcy, MDA, and CRP were significantly higher in PCOS patients with high AOPP than in those with normal AOPP. Fasting insulin, insulin resistance, and Hcy were independent determinants of plasma AOPP. CONCLUSION(S): Increased AOPP may contribute to the increased risk of atherosclerotic cardiovascular disease in women with PCOS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976759     DOI: 10.1016/j.fertnstert.2008.08.016

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  12 in total

1.  Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line.

Authors:  Shaletha Holmes; Meharvan Singh; Chang Su; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2016-05-11       Impact factor: 4.736

2.  Oxidized HDL, Adipokines, and Endothelial Dysfunction: A Potential Biomarker Profile for Cardiovascular Risk in Women with Obesity.

Authors:  Stephen J Peterson; Joseph I Shapiro; Ellen Thompson; Shailendra Singh; Lu Liu; Jeremy A Weingarten; Kathleen O'Hanlon; Angelica Bialczak; Siddharth R Bhesania; Nader G Abraham
Journal:  Obesity (Silver Spring)       Date:  2019-01       Impact factor: 5.002

3.  Assessment of oxidative, inflammatory, and fibrinolytic biomarkers and DNA strand breakage in hypercholesterolemia.

Authors:  Renata da Silva Pereira; Etiane Tatsch; Guilherme Vargas Bochi; Helena Kober; Thiago Duarte; Greice Franciele Feyh dos Santos Montagner; José Edson Paz da Silva; Marta Maria Medeiros Frescura Duarte; Ivana Beatrice Mânica da Cruz; Rafael Noal Moresco
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

4.  Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome.

Authors:  A Makedos; D G Goulis; M Arvanitidou; G Mintziori; A Papanikolaou; A Makedou; D Panidis
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

Review 5.  Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.

Authors:  Héctor F Escobar-Morreale; Manuel Luque-Ramírez; Frank González
Journal:  Fertil Steril       Date:  2010-12-17       Impact factor: 7.329

6.  Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome.

Authors:  Z Kurdoglu; H Ozkol; Y Tuluce; I Koyuncu
Journal:  J Endocrinol Invest       Date:  2011-04-26       Impact factor: 4.256

7.  Reduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: a causative link to polycystic ovarian syndrome.

Authors:  Eleni Kandaraki; Antonis Chatzigeorgiou; Christina Piperi; Eleni Palioura; Sotiria Palimeri; Penelope Korkolopoulou; Michael Koutsilieris; Athanasios G Papavassiliou
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

Review 8.  Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.

Authors:  Krystallenia I Alexandraki; Eleni A Kandaraki; Kalliopi-Anna Poulia; Christina Piperi; Eirini Papadimitriou; Theodoros G Papaioannou
Journal:  touchREV Endocrinol       Date:  2021-04-28

9.  Evaluation of Levels of Advanced Oxidative Protein Products in Patients with Polycystic Ovary Syndrome with and without Chronic Periodontitis: A Cross-Sectional Study.

Authors:  Smriti Dharuman; Supraja Ajith Kumar; Subbusamy Kanakasabapathy Balaji; Usha Vishwanath; Royapuram Parthasarathy Parameshwari; Muthukumar Santhanakrishnan
Journal:  Int J Fertil Steril       Date:  2022-01

10.  Evaluation of a Summary Score for Dyslipidemia, Oxidative Stress and Inflammation (the Doi Score) in Women with Polycystic Ovary Syndrome and its Relationship with Obesity.

Authors:  Iva Perović Blagojević; Svetlana Ignjatović; Djuro Macut; Jelena Kotur-Stevuljević; Ivana Božić-Antić; Jelena Vekić; Jelica Bjekić-Macut; Biljana Kastratović-Kotlica; Zoran Andrić; Dušan Ilić
Journal:  J Med Biochem       Date:  2018-12-01       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.